PBYI vs. VOO

In the year-to-date period, PBYI achieves a 6.07% return, which is significantly higher than VOO's -0.85% return. Over the past 10 years, PBYI has underperformed VOO with an annualized return of -33.75%, while VOO has yielded a comparatively higher 12.64% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Puma Biotechnology, Inc. (PBYI) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PBYI Sharpe Ratio is -0.26, which is lower than the VOO Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of PBYI and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PBYI has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.31%.

The maximum PBYI drawdown since its inception was -99.40%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for PBYI and VOO.

Puma Biotechnology, Inc. (PBYI) has a higher volatility of 20.90% compared to Vanguard S&P 500 ETF (VOO) at 4.44%. This indicates that PBYI's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.